I-Mab announced positive interim data from its U.S. phase 2/3 study of plonmarlimab for the treatment of cytokine release syndrome in patients..

Glenmark and SaNOtize announced an exclusive long term strategic partnership to manufacture, market and distribute..

The UAE announced the approval of Chinese Sinopharm COVID-19 vaccine for children aged 3-17 in the country after its efficacy in that age group...